chr3-191278152-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_198152.5(UTS2B):āc.122A>Cā(p.Asp41Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000144 in 1,388,810 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_198152.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
UTS2B | NM_198152.5 | c.122A>C | p.Asp41Ala | missense_variant | 6/9 | ENST00000340524.10 | |
UTS2B | XM_017006091.2 | c.122A>C | p.Asp41Ala | missense_variant | 5/8 | ||
UTS2B | XM_011512631.3 | c.122A>C | p.Asp41Ala | missense_variant | 5/8 | ||
UTS2B | XM_047447899.1 | c.122A>C | p.Asp41Ala | missense_variant | 5/8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
UTS2B | ENST00000340524.10 | c.122A>C | p.Asp41Ala | missense_variant | 6/9 | 2 | NM_198152.5 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000524 AC: 1AN: 190850Hom.: 0 AF XY: 0.00000957 AC XY: 1AN XY: 104442
GnomAD4 exome AF: 0.00000144 AC: 2AN: 1388810Hom.: 0 Cov.: 25 AF XY: 0.00000145 AC XY: 1AN XY: 691258
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 17, 2024 | The c.122A>C (p.D41A) alteration is located in exon 6 (coding exon 2) of the UTS2B gene. This alteration results from a A to C substitution at nucleotide position 122, causing the aspartic acid (D) at amino acid position 41 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at